Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination: Follow-up of a randomized clinical trial

Robine Donken; Simon R.M. Dobson; Kim D. Marty; Darrel Cook; Chantal Sauvageau; Vladimir Gilca; Marc Dionne; Shelly McNeil; Mel Krajden; Deborah Money; James Kellner; David W. Scheifele; Tobias Kollmann; Julie A. Bettinger; Shuzhen Liu; Joel Singer; Monika Naus; Manish Sadarangani; Gina S. Ogilvie

doi:10.1093/cid/ciz887

Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination: Follow-up of a randomized clinical trial

Robine Donken, Simon R.M. Dobson, Kim D. Marty, Darrel Cook, Chantal Sauvageau, Vladimir Gilca, Marc Dionne, Shelly McNeil, Mel Krajden, Deborah Money, James Kellner, David W. Scheifele, Tobias Kollmann, Julie A. Bettinger, Shuzhen Liu, Joel Singer, Monika Naus, Manish Sadarangani, Gina S. Ogilvie

Decision Sciences

科研成果: 期刊稿件 › 文章 › 同行评审

30 引用（Scopus）

源语言	英语
页（从-至）	1022-1029
页数	8
期刊	Clinical Infectious Diseases
卷	71
期	4
DOI	https://doi.org/10.1093/cid/ciz887
出版状态	已出版 - 8月 15 2020

!!!ASJC Scopus Subject Areas

微生物学（医学）
传染病学

联合国可持续发展目标

此成果有助于实现下列可持续发展目标：

访问文件

10.1093/cid/ciz887

其它文件与链接

引用此

Donken, R., Dobson, S. R. M., Marty, K. D., Cook, D., Sauvageau, C., Gilca, V., Dionne, M., McNeil, S., Krajden, M., Money, D., Kellner, J., Scheifele, D. W., Kollmann, T., Bettinger, J. A., Liu, S., Singer, J., Naus, M., Sadarangani, M., & Ogilvie, G. S. (2020). Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination: Follow-up of a randomized clinical trial. Clinical Infectious Diseases, 71(4), 1022-1029. https://doi.org/10.1093/cid/ciz887

Donken, R, Dobson, SRM, Marty, KD, Cook, D, Sauvageau, C, Gilca, V, Dionne, M, McNeil, S, Krajden, M, Money, D, Kellner, J, Scheifele, DW, Kollmann, T, Bettinger, JA, Liu, S, Singer, J, Naus, M, Sadarangani, M & Ogilvie, GS 2020, 'Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination: Follow-up of a randomized clinical trial', Clinical Infectious Diseases, 卷 71, 号码 4, 页码 1022-1029. https://doi.org/10.1093/cid/ciz887

@article{baf818b09d754565acf5a4285dc8bde0,

title = "Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination: Follow-up of a randomized clinical trial",

keywords = "Human papillomavirus vaccine, Immunization schedule, Immunogenicity, Papillomavirus infections",

author = "Robine Donken and Dobson, {Simon R.M.} and Marty, {Kim D.} and Darrel Cook and Chantal Sauvageau and Vladimir Gilca and Marc Dionne and Shelly McNeil and Mel Krajden and Deborah Money and James Kellner and Scheifele, {David W.} and Tobias Kollmann and Bettinger, {Julie A.} and Shuzhen Liu and Joel Singer and Monika Naus and Manish Sadarangani and Ogilvie, {Gina S.}",

note = "Publisher Copyright: {\textcopyright} The Author(s) 2019.",

year = "2020",

month = aug,

day = "15",

doi = "10.1093/cid/ciz887",

language = "English",

volume = "71",

pages = "1022--1029",

journal = "Clinical Infectious Diseases",

issn = "1058-4838",

publisher = "Oxford University Press",

number = "4",

}

TY - JOUR

T1 - Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination

T2 - Follow-up of a randomized clinical trial

AU - Donken, Robine

AU - Dobson, Simon R.M.

AU - Marty, Kim D.

AU - Cook, Darrel

AU - Sauvageau, Chantal

AU - Gilca, Vladimir

AU - Dionne, Marc

AU - McNeil, Shelly

AU - Krajden, Mel

AU - Money, Deborah

AU - Kellner, James

AU - Scheifele, David W.

AU - Kollmann, Tobias

AU - Bettinger, Julie A.

AU - Liu, Shuzhen

AU - Singer, Joel

AU - Naus, Monika

AU - Sadarangani, Manish

AU - Ogilvie, Gina S.

PY - 2020/8/15

Y1 - 2020/8/15

KW - Human papillomavirus vaccine

KW - Immunization schedule

KW - Immunogenicity

KW - Papillomavirus infections

UR - http://www.scopus.com/inward/record.url?scp=85088973127&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85088973127&partnerID=8YFLogxK

U2 - 10.1093/cid/ciz887

DO - 10.1093/cid/ciz887

M3 - Article

C2 - 31617568

AN - SCOPUS:85088973127

SN - 1058-4838

VL - 71

SP - 1022

EP - 1029

JO - Clinical Infectious Diseases

JF - Clinical Infectious Diseases

IS - 4

ER -

Immunogenicity of 2 and 3 doses of the quadrivalent human papillomavirus vaccine up to 120 months postvaccination: Follow-up of a randomized clinical trial

!!!ASJC Scopus Subject Areas

联合国可持续发展目标

访问文件

其它文件与链接

指纹

引用此